首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Evaluation of metabolomic changes during neoadjuvant chemotherapy combined with bevacizumab in breast cancer using MR spectroscopy
Authors:Leslie R Euceda  Tonje H Haukaas  Guro F Giskeødegård  Riyas Vettukattil  Jasper Engel  Laxmi Silwal-Pandit  Steinar Lundgren  Elin Borgen  Øystein Garred  Geert Postma  Lutgarde M C Buydens  Anne-Lise Børresen-Dale  Olav Engebraaten  Tone F Bathen
Institution:1.Department of Circulation and Medical Imaging - MR Center, Faculty of Medicine and Health Sciences,NTNU - Norwegian University of Science and Technology,Trondheim,Norway;2.K.G. Jebsen Center for Breast Cancer Research, Institute of Clinical Medicine,University of Oslo,Oslo,Norway;3.St. Olavs Hospital,Trondheim University Hospital,Trondheim,Norway;4.NERC Biomolecular Analysis Facility Metabolomics Node (NBAF-B), School of Biosciences,University of Birmingham,Birmingham,UK;5.Department of Cancer Genetics, Oslo University Hospital, Institute for Cancer Research,The Norwegian Radium Hospital,Oslo,Norway;6.Department of Cancer Research and Molecular Medicine, Faculty of Medicine and Health Sciences,NTNU - Norwegian University of Science and Technology,Trondheim,Norway;7.Cancer Clinic, St. Olavs Hospital,Trondheim University Hospital,Trondheim,Norway;8.Department of Pathology, Division of Diagnostics and Intervention,Oslo University Hospital,Oslo,Norway;9.Institute for Molecules and Materials,Radboud University Nijmegen,Nijmegen,The Netherlands;10.Departments of Oncology and Tumor Biology,Oslo University Hospital,Oslo,Norway;11.Department of Clinical Medicine,University of Oslo,Oslo,Norway
Abstract:
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号